Expression of SSEA-1 (Lewisx) on transitional cell carcinoma of the bladder

Urologia Internationalis

Volumn 58, Issue 2, 1997, Pages 69-74

  Konety, Badrinath R ^a,b   Ballou, Byron ^a,b   Jaffe, Ronald ^a,b   Singh, Jagjit ^a,b   Reiland, Jean ^a,b   Hakala, Thomas R ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bladder; Bladder neoplasm; Lewisx; SSEA 1; Transitional cell carcinoma

Indexed keywords

STAGE SPECIFIC EMBRYO ANTIGEN 1;

ADULT; AGED; ARTICLE; BLADDER TUMOR; BLOOD GROUP LEWIS SYSTEM; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; DRUG EFFICACY; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

AGED; ANTIGENS, CD15; CARCINOMA, TRANSITIONAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0031034539     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000282953     Document Type: Article

References (22)

1. Silvcrberg E: Cancer statistics, CA Cancer J Clin 1985:35:5.
2. Bergman S, Javadpour N: The cell surface antigen A, B or O (H) as an indicator of malignant potential in stage A bladder carcinoma: Preliminary report, J Urol 1978:119:49-53.
3. Lange PH, Limas C, Fraley EE: Tissue blood group antigens and prognosis in low stage transitional cell carcinoma of the bladder, J Urol 1978:119:52.
4. Coon JS, McCall A, Miller AW, Farrow GM, Weinstein RS: Expression of blood group related antigens in carcinoma ‘in situ’ of the urinary bladder, Cancer 1985:56:797-804.
5. Solter D, Knowles BB: Monoclonal antibody defining a stage specific mouse embryonic antigen (SSEA-1), Proc Natl Acad Sci USA 1978; 75:5565-5569.
6. Hakamori S, Kobata A: Blood group antigens: in Sela M (ed): The Antigens, New York, Academic Press, 1974, pp 79-140.
7. Kerr MA, McCarthy NC: A carbohydrate differentiation antigen of granulocytes, brain and many tumors, Biochcm Soc Trans 1985:13: 424-426.
8. Rettig WJ, Cordon-Cardo C, Ng JSC, Octtgcn HF, Old LJ, Lloyd KO: High molecular weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants, Cancer Res 1985;45:815-821.
9. Cordon-Cardo C, Reuter VF., Lloyd KO, et al: Blood group related antigens in human urolhc-lium: Enhanced expression of precursor, Le* and Lc: determinants in urothelial carcinoma, Cancer Res 1988.48:4113-4120.
10. Sheinfeld J, Reuter VE, Melamed MR, et al: Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation, J Urol 1990:143:285-288.
11. Shirahama T, Ikoma M, Muramatsu T, Ohi Y: Expression of SSEA 1 carbohydrate antigen correlates with stage, grade and metastatic potential of transitional cell carcinoma of bladder, J Urol 1992:148:1319-1322.
12. Hakamori S, Kannagi R: Glycosphingolipidsas tumor-associated and differentiation markers, J Natl Cancer Inst 1983;71:231-251.
13. Stemberger LA: The unlabclled antibody peroxidase anti-peroxidase (PAP) method; in Sternberg LA (ed): Immunocytochemistry, ed 2, New York, Wiley, 1979, pp 104-169.
14. Hsu SM, Raine L, Fauger H: Comparative study of the peroxidase anti-peroxidase and avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies, Am J Pathol 1981:75:734-740.
15. Lieben M, Jaffc R, Taylor RJ, Ballou B, Solter D, Hakala TR: Detection of SSEA-1 on human renal tumors, Cancer 1987:1404-1408.
16. Mostofi FK, Sobin LH, Torloni H: Histological typing of urinary bladder tumors, International Classification of Tumors, No, 10, Geneva, WHO, 1973.
17. Gooi HC, Feizi T, Kapadia A, Knowles BB, Solter D, Evans MJ: Stage specific embryonic antigen involves alpha 1-3 fucosvlated type 2 blooc group chains, Nature 1981:292:156-158.
18. Dalbagni G, Reuter VE, Sheinfeld J, Fradet Y, Fair W, Cordon-Cardo C: Cell surface differentiation antigens of normal urothelium and bladder tumors, Semin Surg Oncol, 1992:8: 293-299.
19. Sagerman PM, Saigo PE, Sheinfeld J, Chary-tonowicz E, Cordon-Cardo C: Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A21I antigens, Acta Cytol 1994:38:517-523.
20. Parham DM, Morton K, Coghill G, Robertson AJ, Kerr MA: Expression of CD 15 antigen in urinary bladder transitional cell carcinoma, J Clin Pathol, 1990:43:541-543.
21. Nakamori S, Kameyama S, Iniaoka S, et al: Increased expression of sialyl Lewis* antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study, Cancer Res 1993;53:3632-3637.
22. Sarkis AS, Charytonowicz E, Cordon-Cardo Y, et al: Blood group antigen expression in bladder tumors: An immunohistochemical study of superficial bladder lesions, J Exp Clin Cancer Res 1994;13:139-144